Innoviva (INVA) Misses Q4 EPS by 6c

Innoviva (NASDAQ: INVA) reported Q4 EPS of $0.26, $0.06 worse than the analyst estimate of $0.32. Revenue for the quarter came in at $91.81 million versus the consensus estimate of $84.3 million.

For earnings history and earnings-related data on Innoviva (INVA) click here.

You May Also Be Interested In

• Oppenheimer Assumes Inova Technology, Inc. (INVA) at Outperform
• TriSalus Life Sciences, Inc. (TLSI) PT Raised to $12 at H.C. Wainwright
• Meta Platforms (META) PT Raised to $860 at Cantor Fitzgerald on AI Capability Advances